Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Leukemia|February 25, 2025
Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN)Kirsi Manz, Florian H Heidel, Steffen Koschmieder, et al.
Targeted Oncology|July 17, 2026
From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor BoardTabea Fröhlich, Ulrich Lehmann, Tanja Reineke-Plaaß, et al.
Neurological Research and Practice|December 16, 2020
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)Kathrin Reetz, Ralf-Dieter Hilgers, Susanne Isfort, et al.
Annals of Hematology|December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study groupSteffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.
Hemasphere|April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified CriteriaMareike Tometten, Martin Kirschner, Robert Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study GroupKirsten Fischer, Paula Cramer, Raymonde Busch, et al.
Blood Advances|February 12, 2025
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohortMareike Tometten, Fabian Beier, Martin Kirschner, et al.
Annals of Hematology|August 17, 2023
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) StudySusanne Isfort, Kirsi Manz, Lino L Teichmann, et al.
Cancers|August 27, 2021
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN BioregistryJudith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, et al.
Blood Advances|July 8, 2018
Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemiaAnne-Sophie Bouillon, Monica S Ventura Ferreira, Shady Adnan Awad, et al.
Pageof 5